A research team at Fujita Health University led by Professor Tsuyoshi Miyakawa has uncovered a novel mechanism of cellular ...
Nearly 90 years after Ugo Cerletti and Lucio Bini introduced electroconvulsive therapy (ECT), brain stimulation therapies ...
Nearly 90 years after Ugo Cerletti and Lucio Bini introduced electroconvulsive therapy (ECT), brain stimulation therapies ...
Neuronal Stimulation Induces Dematuration of Adult NeuronsNearly 90 years after Ugo Cerletti and Lucio Bini introduced electroconvulsive therapy ...
The rapid progression of genetic engineering, regenerative medicine, and pharmacology has positioned gene, cell, and ...
Background Pancreatic ductal adenocarcinoma (PDAC) is largely refractory to immune checkpoint blockade, owing to its ...
Remix Therapeutics (Remix), Inc., a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced ...
When the Good Guys Go Rogue In the battle against cancer, it’s not just a showdown between the tumor and treatments.
Share on Pinterest Could GLP-1s hold the key to protecting people with diabetes against long COVID? Image credit: Jon Challicom/ Getty Images Some people develop long COVID after a SARS-CoV-2 ...
THE QUAINT city of Glasgow provided the backdrop for Europe’s premier nephrology meeting, the 63rd annual European Renal ...
Harvard geneticist Dr. David Sinclair's OSK therapy (ER-100) enters human trials. Learn how cellular reprogramming could ...
The molecular machinery that normally builds proteins inside cells has now taken on a new role as a "switch." A research team ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results